We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Clinical Applications of New DNA Diagnostic Technology on the Management of Cancer Patients

Janet D. Rowley, MD; Jon C. Aster, MD; Jeffrey Sklar, MD, PhD
JAMA. 1993;270(19):2331-2337. doi:10.1001/jama.1993.03510190087032.
Text Size: A A A
Published online


THIS ARTICLE presents a summary of the results of investigations to detect the various genetic changes that have been identified in malignant cells, concentrating on those malignant diseases that have been well characterized genetically. Various techniques are reviewed elsewhere.1 The correlation of the genetic changes with features that aid in the distinction of different tumors or that have prognostic significance will be emphasized. The explosive growth in this area of clinical investigation causes any review of this sort to become out of date rapidly. Nonetheless, these examples are important illustrations of the future of medical practice. Detailed summaries of chromosome abnormalities in cancer have been described previously.2,3 The article is divided into two major parts, hematologic malignant diseases and solid tumors. At present, we know much more about the hematologic disorders, especially leukemia and lymphoma.4 This is rapidly changing as many laboratories are actively investigating the genetic


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.